164 related articles for article (PubMed ID: 21284495)
1. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.
Immonen K; Finne P; Grönhagen-Riska C; Pettersson T; Klaukka T; Kautiainen H; Hakala M
Amyloid; 2011 Mar; 18(1):25-8. PubMed ID: 21284495
[TBL] [Abstract][Full Text] [Related]
2. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases.
Immonen K; Finne P; Hakala M; Kautiainen H; Pettersson T; Grönhagen-Riska C
J Rheumatol; 2008 Jul; 35(7):1334-8. PubMed ID: 18609734
[TBL] [Abstract][Full Text] [Related]
3. Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007.
Rantalaiho V; Kautiainen H; Virta L; Korpela M; Möttönen T; Puolakka K
Scand J Rheumatol; 2011 Jan; 40(1):16-21. PubMed ID: 20726683
[TBL] [Abstract][Full Text] [Related]
4. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis.
Savolainen HA; Isomäki HA
J Rheumatol; 1993 Jul; 20(7):1201-3. PubMed ID: 8371218
[TBL] [Abstract][Full Text] [Related]
5. Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis.
Immonen K; Savolainen A; Kautiainen H; Hakala M
J Rheumatol; 2008 May; 35(5):907-12. PubMed ID: 18381779
[TBL] [Abstract][Full Text] [Related]
6. [Does the basic therapy affect the development of secondary amyloidosis in rheumatoid arthritis?].
Prokaeva TB; Alekberova ZS; Radenska-Lopovok SG; Tiitinen S; Kaarela K; Kautiainen H
Ter Arkh; 1995; 67(5):47-9. PubMed ID: 7638779
[TBL] [Abstract][Full Text] [Related]
7. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8.
Rantalaiho VM; Kautiainen H; Järvenpää S; Virta L; Pohjolainen T; Korpela M; Möttönen T; Puolakka K
Ann Rheum Dis; 2013 May; 72(5):672-7. PubMed ID: 22679306
[TBL] [Abstract][Full Text] [Related]
8. Dialysis treatment in children with amyloidosis due to juvenile rheumatoid arthritis.
Sieniawska M; Roszkowska-Blaim M; Wojciechowska B
Turk J Pediatr; 1996; 38(1):59-66. PubMed ID: 8819622
[TBL] [Abstract][Full Text] [Related]
9. More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases.
Vasala M; Immonen K; Kautiainen H; Hakala M
Scand J Rheumatol; 2010 Nov; 39(6):461-5. PubMed ID: 20560815
[TBL] [Abstract][Full Text] [Related]
10. Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis.
Kaipiainen-Seppänen O; Myllykangas-Luosujärvi R; Lampainen E; Ikäheimo R
Scand J Rheumatol; 2000; 29(4):232-5. PubMed ID: 11028844
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
[No Abstract] [Full Text] [Related]
12. Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study.
Kristensen SL; Fosbøl EL; Kamper AL; Køber L; Hommel K; Lamberts M; Abildstrøm SZ; Blicher TM; Torp-Pedersen C; Gislason GH
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):428-34. PubMed ID: 22344680
[TBL] [Abstract][Full Text] [Related]
13. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
[TBL] [Abstract][Full Text] [Related]
14. [What has become of inflammatory amyloidosis?].
Grateau G
Rev Prat; 2003 Mar; 53(5):516-9. PubMed ID: 12722610
[TBL] [Abstract][Full Text] [Related]
15. [Secondary amyloidosis in rheumatoid arthritis. A clinical study of 29 patients].
Fiter Aresté J; Nolla Solé JM; Gómez Vaquero C; Valverde García J; Roig Escofet D
An Med Interna; 1999 Dec; 16(12):615-9. PubMed ID: 10686712
[TBL] [Abstract][Full Text] [Related]
16. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland.
Laiho K; Tiitinen S; Kaarela K; Helin H; Isomäki H
Clin Rheumatol; 1999; 18(2):122-3. PubMed ID: 10357116
[TBL] [Abstract][Full Text] [Related]
17. [Revision of the recommendations of the Commission on Pharmacotherapy of the German society for Rheumatology. Therapy with tumour necrosis factor blockers for inflammatory rheumatic illnesses].
Manger B; Michels H; Nüsslein HG; Schneider M; Sieper J;
Z Rheumatol; 2007 Feb; 66(1):72-5. PubMed ID: 17221253
[TBL] [Abstract][Full Text] [Related]
18. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
19. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
[TBL] [Abstract][Full Text] [Related]
20. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement.
Hakala M; Pöllänen R; Nieminen P
J Rheumatol; 1993 Oct; 20(10):1674-8. PubMed ID: 8295178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
